Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell

References

• Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. (2009). Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia, 57, 1192–1203.
   PubMed Web of Science ®Google Scholar
• Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI. (2010). Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol, 299, 760–770.
   PubMed Web of Science ®Google Scholar
• Brown DM, Ruoslahti E. (2004). Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell, 5, 365–374.
   PubMed Web of Science ®Google Scholar
• Bushman FD. (2007). Retroviral integration and human gene therapy. J Clin Invest, 117, 2083–2086.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem, 98, 1076–1084.
   PubMed Web of Science ®Google Scholar
• Chiu RC. (2008). MSC immune tolerance in cellular cardiomyoplasty. Semin Thorac Cardiovasc Surg, 20, 115–118.
   PubMedGoogle Scholar
• Dennis JE, Cohen N, Goldberg VM, Caplan AI. (2004). Targeted delivery of progenitor cells for cartilage repair. J Orthop Res, 22, 735–741.
   PubMed Web of Science ®Google Scholar
• Dixon JA, Gorman RC, Stroud RE, Bouges S, Hirotsugu H, Gorman JH3rd, Martens TP, Itescu S, Schuster MD, Plappert T, St John-Sutton MG, Spinale FG. (2009). Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation, 120, S220–S229.
   PubMed Web of Science ®Google Scholar
• Essler M, Ruoslahti E. (2002). Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA, 99, 2252–2257.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J, 20, 661–669.
   PubMed Web of Science ®Google Scholar
• Hoffman JA, Giraudo E, Singh M, Zhang L, Inoue M, Porkka K, Hanahan D, Ruoslahti E. (2003). Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell, 4, 383–391.
   PubMed Web of Science ®Google Scholar
• Ishikane S, Ohnishi S, Yamahara K, Sada M, Harada K, Mishima K, Iwasaki K, Fujiwara M, Kitamura S, Nagaya N, Ikeda T. (2008). Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells, 26, 2625–2633.
   PubMed Web of Science ®Google Scholar
• Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ. (2007). Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun, 354, 700–706.
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet, 367, 113–121.
   PubMed Web of Science ®Google Scholar
• Järvinen TA, Ruoslahti E. (2007). Molecular changes in the vasculature of injured tissues. Am J Pathol, 171, 702–711.
   PubMed Web of Science ®Google Scholar
• Kang D, Hamasaki N. (2003). Mitochondrial oxidative stress and mitochondrial DNA. Clin Chem Lab Med, 41, 1281–1288.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. (2009). Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell, 4, 206–216.
   PubMed Web of Science ®Google Scholar
• Kean T, Roth S, Thanou M. (2005). Trimethylated chitosans as non-viral gene delivery vectors: Cytotoxicity and transfection efficiency. J Control Release, 103, 643–653.
   PubMed Web of Science ®Google Scholar
• Ko IK, Kean TJ, Dennis JE. (2009). Targeting mesenchymal stem cells to activated endothelial cells. Biomaterials, 30, 3702–3710.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Wang B, Ruoslahti E. (1994). Isolation of a highly specific ligand for the α 5 β 1 integrin from a phage display library. J Cell Biol, 124, 373–380.
   PubMed Web of Science ®Google Scholar
• Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, Meyer GP, Ganser A, Drexler H, Wollert KC. (2008). Bone marrow cells are a rich source of growth factors and cytokines: Implications for cell therapy trials after myocardial infarction. Eur Heart J, 29, 2851–2858.
   PubMed Web of Science ®Google Scholar
• Kuethe F, Richartz BM, Sayer HG, Kasper C, Werner GS, Höffken K, Figulla HR. (2004). Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol, 97, 123–127.
   PubMed Web of Science ®Google Scholar
• Kumar S, Ponnazhagan S. (2007). Bone homing of mesenchymal stem cells by ectopic α 4 integrin expression. FASEB J, 21, 3917–3927.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Ringdén O. (2006). Mesenchymal stem cells: Properties and role in clinical bone marrow transplantation. Curr Opin Immunol, 18, 586–591.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol, 31, 890–896.
   PubMed Web of Science ®Google Scholar
• Lee RJ, Fang Q, Davol PA, Gu Y, Sievers RE, Grabert RC, Gall JM, Tsang E, Yee MS, Fok H, Huang NF, Padbury JF, Larrick JW, Lum LG. (2007). Antibody targeting of stem cells to infarcted myocardium. Stem Cells, 25, 712–717.
   PubMed Web of Science ®Google Scholar
• Lennon, D., Haynesworth, S., Bruder, S., Jaiswal, N. & Caplan, A. 1996. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. Vitro Anim Cell Dev Biol, 32, 602–611.
   Web of Science ®Google Scholar
• Lien CY, Chih-Yuan Ho K, Lee OK, Blunn GW, Su Y. (2009). Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res, 24, 837–848.
   PubMed Web of Science ®Google Scholar
• Liu C, Bhattacharjee G, Boisvert W, Dilley R, Edgington T. (2003). In vivo interrogation of the molecular display of atherosclerotic lesion surfaces. Am J Pathol, 163, 1859–1871.
   PubMed Web of Science ®Google Scholar
• Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z. (2010). Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther, 12, R210.
   PubMed Web of Science ®Google Scholar
• Lum LG, Sen M. (2001). Activated T-cell and bispecific antibody immunotherapy for high-risk breast cancer. Bench to bedside. Acta Haematol, 105, 130–136.
   PubMed Web of Science ®Google Scholar
• Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL. (2000). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res, 9, 841–848.
   PubMedGoogle Scholar
• Malgieri A, Kantzari E, Patrizi MP, Gambardella S. (2010). Bone marrow and umbilical cord blood human mesenchymal stem cells: State of the art. Int J Clin Exp Med, 3, 248–269.
   PubMed Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55–63.
   PubMed Web of Science ®Google Scholar
• Ojha N, Roy S, Radtke J, Simonetti O, Gnyawali S, Zweier JL, Kuppusamy P, Sen CK. (2008). Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 294, H2435–H2443.
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.
   PubMed Web of Science ®Google Scholar
• Penn MS, Mangi AA. (2008). Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res, 102, 1471–1482.
   PubMed Web of Science ®Google Scholar
• Pilch J, Brown DM, Komatsu M, Järvinen TA, Yang M, Peters D, Hoffman RM, Ruoslahti E. (2006). Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci USA, 103, 2800–2804.
   PubMed Web of Science ®Google Scholar
• Rao VS, La Bonte LR, Xu Y, Yang Z, French BA, Guilford WH. (2007). Alterations to myofibrillar protein function in nonischemic regions of the heart early after myocardial infarction. Am J Physiol Heart Circ Physiol, 293, 654–659.
   Google Scholar
• Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R. (2008). Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med, 14, 181–187.
   PubMed Web of Science ®Google Scholar
• Sarkar D, Vemula PK, Teo GS, Spelke D, Karnik R, Wee le Y, Karp JM. (2008). Chemical engineering of mesenchymal stem cells to induce a cell rolling response. Bioconjug Chem, 19, 2105–2109.
   PubMed Web of Science ®Google Scholar
• Schinköthe T, Bloch W, Schmidt A. (2008). In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev, 17, 199–206.
   PubMed Web of Science ®Google Scholar
• Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, Gutman MR, Hatzistergos KE, Oskouei BN, Zimmet JM, Young RG, Heldman AW, Lardo AC, Hare JM. (2008). Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol, 294, 2002–2011.
   PubMed Web of Science ®Google Scholar
• Sen M, Wankowski DM, Garlie NK, Siebenlist RE, Van Epps D, LeFever AV, Lum LG. (2001). Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumors. J Hematother Stem Cell Res, 10, 247–260.
   PubMedGoogle Scholar
• Srinivasan M, Domanico SZ, Kaumaya PT, Pierce SK. (1993). Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response. Eur J Immunol, 23, 1011–1016.
   PubMed Web of Science ®Google Scholar
• Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E. (2009). Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell, 16, 510–520.
   PubMed Web of Science ®Google Scholar
• Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML. (2007). Myocardial infarct size measurement in the mouse chronic infarction model: Comparison of area- and length-based approaches. J Appl Physiol, 102, 2104–2111.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Li TS, Suzuki R, Kobayashi T, Ito H, Ikeda Y, Matsuzaki M, Hamano K. (2006). Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol, 291, H886–H893.
   PubMed Web of Science ®Google Scholar
• Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E. (2009). C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA, 106, 16157–16162.
   PubMed Web of Science ®Google Scholar
• Terrovitis J, Charitos C, Dolou P, Papalois A, Eleftheriou A, Tsolakis E, Charitos E, Mponios M, Karanastasis G, Koudoumas D, Agapitos E, Nanas JN. (2004). No effect of stem cell mobilization with GM-CSF on infarct size and left ventricular function in experimental acute myocardial infarction. Basic Res Cardiol, 99, 241–246.
   PubMed Web of Science ®Google Scholar
• Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93–98.
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol, 8, 726–736.
   PubMed Web of Science ®Google Scholar
• VCCLAB. (2005). Virtual computational chemistry laboratory [Online]. Available at: http://www.vcclab.org. Accessed on 14 January 2008.
   Google Scholar
• Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, Zhang J. (2007). Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation, 115, 1866–1875.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hoffman JA, Ruoslahti E. (2005). Molecular profiling of heart endothelial cells. Circulation, 112, 1601–1611.
   PubMed Web of Science ®Google Scholar
• Zhao TC, Tseng A, Yano N, Tseng Y, Davol PA, Lee RJ, Lum LG, Padbury JF. (2008). Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol, 104, 1793–1800.
   PubMed Web of Science ®Google Scholar